Diagnostic Modeling for Pedal Fat Pad Atrophy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-01-31

Study Completion Date

2020-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators hypothesize that there is a difference in plantar tissue thickness, plantar pressure, and pain score in patients diagnosed with plantar fat pad atrophy compared to healthy, foot-type matched controls. Results will be measured objectively using ultrasound for tissue thickness, optical pedobarograph for plantar pressure, and Manchester foot pain and disability index (MFPDI) for pain score. Furthermore, investigators predict that these results will help establish criteria for fad pad atrophy diagnosis in the clinic as well as determine which patients would receive greatest benefit from fat grafting to the foot.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Fat Grafting for Pedal Fat Pad Atrophy in Diabetics

NCT02074683

Pedal Pad Atrophy Diabetes Mellitus

COMPLETED NA

Thickness of the Plantar Fascia in Stretched and Relaxed Positions in Patients With Plantar Fasciopathy

NCT03291665

Plantar Fasciopathy

COMPLETED

Perforating Fat Injections for Plantar Fasciosis

NCT02855983

Plantar Fascia

COMPLETED NA

Fat Grafting for Pedal Fat Pad Atrophy

NCT01796808

Pedal Fat Pad Atrophy

COMPLETED NA

Morphological and Functional Evaluation of Adult Flat Foot Before and After Corrective Surgery

NCT04174482

Flat Feet

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Human feet must bear the entire weight of the body. Feet have fat pads on their plantar surface that act as shock absorbers between the skin and bone. However, repetitive mechanical stress throughout a person's lifetime leads to gradual atrophy of these fat pads. In addition to this age-related degeneration, fat pad atrophy can be caused by other mechanisms such as abnormal foot mechanics, steroid use, and collagen vascular disease. Regardless of the cause, many patients with plantar fat pad atrophy experience considerable pain and loss of function.

Previous studies have negatively correlated plantar soft tissue thickness with plantar pressure, with the loss of plantar fat being a fundamental mechanism associated with pressure-related foot disorders. Increased pressure from fat pad atrophy is commonly managed with padded socks, insoles, and shoe modification. However, these extrinsic strategies are totally dependent on patient compliance, and devices must be replaced as soon as they begin to break down. Another treatment option includes silicone injections into the plantar aspect of the foot. In one study, patients receiving silicone treatment experienced increased plantar tissue thickness and decreased plantar pressure, but these cushioning properties decreased over time and the need for additional booster injections was ultimately suggested. Furthermore, silicone has been known to migrate away from the injection site and has been found in the inguinal lymph nodes of patients.

A different strategy that is gaining momentum is autologous fat grafting to the foot. Taking a patient's own tissue, often from the abdomen or thigh, and transplanting it to areas of plantar fat pad atrophy may reduce pressure in a more natural and permanent manner. Only one study to date has been published on autologous fat grafting to the foot, but the patients were receiving concurrent surgical procedures with their fat grafting and the results were reported subjectively by the patients.

In this study, the investigators hypothesize that there is a difference in plantar tissue thickness, plantar pressure, and pain score in patients diagnosed with plantar fat pad atrophy compared to healthy, foot-type matched controls. Results will be measured objectively using ultrasound for tissue thickness, optical pedobarograph for plantar pressure, and Manchester foot pain and disability index (MFPDI) for pain score. Furthermore, the investigators predict that these results will help establish criteria for fad pad atrophy diagnosis in the clinic as well as determine which patients would receive greatest benefit from fat grafting to the foot.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fat Pad Atrophy Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

Healthy Adults without foot pain

Ultrasound of the foot

Intervention Type OTHER

An ultrasound will be used to determine the thickness of the fat pad

Pedobarograph Measurements

Intervention Type OTHER

This non-invasive device measures the force and pressure of the foot while standing and walking.

Manchester Foot Pain and Disability Index

Intervention Type OTHER

This is a patient completed questionnaire that assesses level of function from the past month specific to foot pain.

DIsease group

Adults diagnosed with fat pat atrophy and report symptoms of foot pain and have participated in clinical trial to treat fat pad atrophy.

Ultrasound of the foot

Intervention Type OTHER

An ultrasound will be used to determine the thickness of the fat pad

Pedobarograph Measurements

Intervention Type OTHER

This non-invasive device measures the force and pressure of the foot while standing and walking.

Manchester Foot Pain and Disability Index

Intervention Type OTHER

This is a patient completed questionnaire that assesses level of function from the past month specific to foot pain.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound of the foot

An ultrasound will be used to determine the thickness of the fat pad

Intervention Type OTHER

Pedobarograph Measurements

This non-invasive device measures the force and pressure of the foot while standing and walking.

Intervention Type OTHER

Manchester Foot Pain and Disability Index

This is a patient completed questionnaire that assesses level of function from the past month specific to foot pain.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Aged 18 years or older
2. Patients without foot pain at the plantar surface of the foot near the head of the metatarsals
3. 6 months post any surgical intervention to the foot
4. Subjects must be determined by the PI or a Co-Investigator to not suffer from pedal pad atrophy

Exclusion Criteria

1. Age less than 18 years
2. Inability to provide informed consent
3. Feet with open ulcerations or osteomyelitis
4. Diabetics: Type I and II
5. Active infection anywhere in the body
6. Diagnosed with cancer within the last 12 months and /or presently receiving chemotherapy or radiation treatment
7. Pregnancy
8. Tobacco use: Last use within 1 year per patient report

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes